Skip to main content
. 2019 Jun 20;6(4):774–783. doi: 10.1002/ehf2.12454

Figure 2.

Figure 2

Number and percentage of patients taking each medication class and reasons for non‐prescription: (A) angiotensin‐converting enzyme inhibitors or angiotensin receptor blocker/ARNI, (B) beta‐blockers, and (C) mineralocorticoid receptor antagonist.